Trial NCT01916187

View at ClinicalTrials.gov 
Org. Study IDs: I212

Last trial update was posted on 2020-09-21

MeSH Interventions

Imetelstat Motesanib diphosphate

MeSH Conditions

Neuroblastoma

Other Conditions


Stopping Reasons

drug company withdrew support following re-examination of benefit-risk assessment for the investigational use of imetelstat in this population

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID